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Background: Common variable immunodeficiency (CVID) is a disorder characterized by hypogammaglobulinemia
without a known predisposing cause.
Case presentation: We report a 36-year-old man who had suffered membranoproliferative glomerulonephritis
(MPGN) in his childhood, later diagnosed with CVID at 35 years of age. He presented at our hospital with signs of
proteinuria. A renal biopsy revealed he suffered from focal segmental glomerulosclerosis (FSGS), possibly due to
obesity and hypertension, not CVID - associated MPGN.
Conclusion: This is the first case report of FSGS in a CVID patient. In this case, we have to pay attention not only to
the treatment of obesity and hypertension for FSGS but also to the recurrence of immune-complex
glomerulonephritis such as MPGN, in case of the restoration of hypogammaglobulinemia.
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Patients with hypogammaglobulinemia seem to be less
susceptible to immune complex- and complement- related
nephritis, such as MPGN, membranous glomerulonephritis
(MN), and lupus nephritis. Indeed, there have been few
reports of glomerular nephritis in patients with hypogam-
maglobulinemia, with the exception of three cases whom
developed glomerular nephritis during intravenous immu-
nogloburin (IVIG) treatment [1-3].
FSGS is one of the glomerulonephritis which is charac-
terized by podocyte damage. The pathologic classification
of FSGS is categorized as primary and secondary, the
latter being caused by human immunodeficiency virus
(HIV)-associated, heroin, familial forms, drug toxicities, as
well as structural-functional adaptations to glomerular
hyperfiltration such as obesity, hypertension, reflux* Correspondence: hauchida@md.okayama-u.ac.jp
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reproduction in any medium, provided the ornephropathy, etc. Detailed mechanisms for the develop-
ment of this disease are still unclear, but Changli Wei
et al. found recently that a circulating, soluble form of the
urokinase receptor (suPAR) can activate podocyte b3
integrin, leading to FSGS pathology [4].
Here, we report a case of hypertension and obesity-
related FSGS in a CVID patient who had suffered
MPGN in his childhood.Case presentation
The patient in this report was a 36-year-old Japanese
man. He had a history of continuation of nephrotic pro-
teinuria and microscopic hematuria since the age of
7 years. Although information on the therapy and pro-
gress of these diseases were not fully available, gluco-
corticoid and other immunosuppressant therapy were
initiated at the age of 7 years in a hospital. Renal biopsy
was performed at the age of 14 years, with the diagnosis
of MPGN. Immunosuppressant therapy was terminated
due to the absence of active findings in the glomeruli.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mild proteinuria continued.
Because of recurrent bacterial infections at 35 years of
age, he consulted his doctor, and initial testing revealed
low levels of serum IgG, IgA, and IgM. After a detailed
examination by our on-site hematologist, including
bone marrow examination and genetic analysis, he was
diagnosed with CVID although he had no family history
of recurrent infections or immunoglobulin deficiencies.
Since his serum IgG level was not low enough to be
considered unsafe, there was no follow-up therapeutic
treatment including IVIG. He was also diagnosed with
hypertension and advised to start the treatment with an
antihypertensive drug, but he refused at that time. It
should also be noted that during the detailed examination
for the diagnosis of CVID, papillary thyroid carcinoma
happened to be found; surgery was recommended im-
mediately and a thyroidectomy was performed.
At the age of 36 years, his primary physician diagnosed
increased proteinuria [over 1.0 g/day (U-pro/Cr : 1.3 g/gCr)],
and the patient thereafter came to our hospital. At the
first visit, he presented with mild proteinuria (U-pro/Cr :
0.61 g/gCr) and glomerular hyperfiltration (24hCCr :
175.4 ml/min). Two months later, he was admitted to
our hospital the renal biopsy because of mild, persistent
proteinuria.Table 1 Laboratory data on admission
Blood cell count
WBC 7800/μL Na
RBC 571× 104/μL K
Hb 16.3 g/dl Cl
Ht 48.6% Ca




Alb 4.5 g/dL Serological test
AST 17 IU/L IgG
ALT 25 IU/L IgA
T-cho 194 mg/dL IgM
LDL-cho 128 mg/dL C3
HDL-cho 33 mg/dL C4
UA 6.9 mg/dL CH50
BUN 11.3 mg/dL ANA
Cr 0.86 mg/dL
WBC : white blood cell, RBC : red blood cell, Hb : hemoglobin, Ht : hematocrit, Plt : p
ALT : alanine aminotransferase, T-cho : total cholesterol, LDL-cho : low-density lipopr
BUN : blood urea nitrogen, Cr : creatinine, Na : sodium, K : potassium, Cl : chloride, C
protein, IgG : immunoglobulin G, IgA : immunoglobulin A, IgM : immunoglobulin M,
ANA : antinuclear antibody, NAG : N-acetyl-β-glucosaminidase, β2M : β2microglobuli
clearance.On admission, the patient’s height was 171.8 cm, body
weight was 81.6 kg, body mass index was 28.2 kg/m2,
blood pressure was 115/85 mmHg, body temperature
was 36.4°C. His cardiac and pulmonary function
appeared normal and no edema was seen. He snored
terribly, implying that he had obstructive sleep apnea.
Laboratory data upon admission is shown in Table 1.
Serologic testing for HIV-1/HIV-2 was negative. Renal
biopsy was performed at day 2. Immunofluorescence
microscopy showed no specific staining of immunogloburin,
complement, or fibrinogen. Histopathology showed that
obtained glomeruli were enlarged (max and mean
diameter of glomeruli was 270 and 220 μM). Double
contours of capillary walls and mild arteriolosclerosis
were found. Segmental glomerulosclerosis in perihilar
lesion was observed in two glomeruli, one of which
contained perihilar hyalinosis and podocyte hyperplasia
(Figure 1). In electron microscopic observation, electron-
dense deposits were visible within the mesangial, para-
mesangial, and subendotherial space, but the density of
the subendotherial deposits appeared sparser than
typical dense deposits, implying that these deposits
appeared to be formed previously (Figure 1). Given
these observation, the patient was diagnosed as FSGS,
possibly due to obesity and hypertension. At the same
time, renal biopsy showed previous MPGN.Urinalysis
139 mEq/L Specific gravity 1.020
4.6 mEq/L PH 5.5
104 mEq/L Protein 1+
9.2 mg/dL Occult blood -
3.2 mg/dL Glucose -
6.0% RBC <1/HPF
0.14 mg/dl WBC <1/HPF
Cast -
NAG 23.4 U/mL
473.4 mg/dL β2M 0.100 mg/L
118.5 mg/dL
35.5 mg/dL U-protein 0.45 g/day




latelet, TP : total protein, Alb : albumin, AST : aspartate aminotransferase,
otein cholesterol, HDL-cho : high-density lipoprotein cholesterol, UA : uric acid,
a : calcium, P : phosphorus, HbA1c : hemoglobin A1c, CRP : cross-reactive
C3 : complement C3, C4 : complement C4, CH50 : hemolytic complement,




Figure 1 Light microscopic analysis (A-D) and electron microscopy analysis (E,F) Light microscopic analysis (A-D) and electron
microscopy analysis (E,F). A : A glomerulus showed podocyte hyperplasia (open arrowhead). Periodic acid-Schiff stain. B : Segmental
glomerulosclerosis in perihilar lesion was observed in two glomeruli. This glomerulus contained perihilar hyalinosis (arrowheads). Periodic acid
silver methenamine stain. C : Many glomerulus showed double contours of capillary walls (arrows). Periodic acid silver methenamine stain.
D : Mild arteriolosclerosis were found (open arrows). Masson trichrome stain. E : Electron-dense deposits was observed within the mesangial and
para-mesangial region (open arrows). F : A few electron-dense deposits were found within subendothelial space (arrows), but their densities
looked sparser than typical dense deposits, implying that these deposits appeared to be formed previously.
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CVID is a disorder characterized by hypogammaglobuli-
nemia without a known, predisposing cause [5]. Mean-
while, immune complex and complement systems are
thought to play an important role on the pathogenesis of
nephritis, such as MPGN and MN. Since immunodefi-
ciency diseases, such as CVID and X-linked agammaglobu-
linemia, cause extremely low levels of immunoglobulin,
patients diagnosed with these seem to have low incidence
of MPGN or MN. Indeed, as far as we know, there
have been only three previous case reports of nephritis
associated with hypogammaglobulinemia due to im-
munodeficiency diseases. Two of these cases were
MPGN and one was MN. In each case, nephritis was
developed during IVIG treatment [1-3]. On the other
hand, there is a paradoxical relationship between im-
munodeficiency diseases and autoimmune diseases.
For example, Barnett et al. has reported that X-linked
agammaglobulinemia is associated with polyarticulararthritis and inflammatory bowel diseases. Barnett
et al. has also reported that CVID is associated with
rheumatoid arthritis, pernicious anemia, and hemolytic
anemia [6-8]. The precise mechanism linking CVID
with these diseases still remains unclear.
FSGS, clinical-pathologic syndrome of proteinuria
associated with focal and segmental sclerotic glomerular
lesions, is characterized by podocyte damage. The pathologic
classification of FSGS is categorized as primary and
secondary, the latter of which is caused by HIV-associated,
heroin, familial forms, drug toxicities, but also by structural-
functional adaptations to glomerular hyperfiltration
such as obesity, hypertension, reflux nephropathy, and
so on. A number of morphologic variants of primary
and secondary focal sclerosis are now recognized, based
on a 2004 Columbia classification system, including
FSGS-not otherwise specified (NOS), perihilar, cellular,
tip, and collapsing variants. Recently, Changli Wei et al.
found that a circulating, soluble form of the urokinase
Tsuji et al. BMC Nephrology 2012, 13:46 Page 4 of 4
http://www.biomedcentral.com/1471-2369/13/46receptor (suPAR) can activate podocyte b3 integrin,
leading to FSGS pathology, which provides new insight
into this disease and may have important clinical impli-
cations [4].
In our case, differential diagnosis before renal biopsy
appeared somewhat difficult because this patient had
suffered MPGN in his childhood. In addition, the patient
had many complications such as obesity, hypertension,
post operative-papillary thyroid carcinoma, and CVID.
We considered several possibilities, recurrence of MPGN,
CVID-related nephritis, malignancy related nephritis, etc.
Renal biopsy finally revealed this patient to have FSGS.
According to The Columbia FSGS Classification, this
patient was categorized as perihilar variant which was
normally due to glomerular hypertension [9]. Namely, it is
likely that metabolic disorder, relative to his obesity and
hypertension, might have “encouraged” the development
of FSGS. Renal biopsy also implied previous MPGN at the
same time. There was no clear relationship between our
findings and the patient’s chronic, present proteinuria.
Since his episode of past MPGN was successfully treated,
we could find no link between MGPN and CVID for this
case. We started his treatment with diet, exercise, angio-
tensin receptor blocker (ARB), and statin therapy.
Since hypogammaglobulinemia due to CVID may disturb
immune complex and complement system, there is a
possibility that current CVID prevents the development
of MPGN. In case of recovery of CVID, restoration
from hypogammaglobulinemia may cause the recur-
rence of MPGN through the activation of immune
complex and complement system. Therefore, in the
present case, we have to pay attention not only to the
treatment of obesity and hypertension for FSGS but
also to the recurrence of immune-complex related
glomerulonephritis such as MPGN.
In conclusion, we report for the first time a case of
CVID patient with FSGS. Detection of proteinuria in a
CVID patient is rare. In the case of CVID patient with
proteinuria, we have to take many possibilities into
consideration. Therefore, renal biopsy should be an
important tool for a precise and proper diagnosis.Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompanying
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